» Authors » Alexandre A S Soares

Alexandre A S Soares

Explore the profile of Alexandre A S Soares including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 108
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Breder I, Wolf V, Soares A, de Carvalho L, Kimura-Medorima S, Cintra R, et al.
Diabetes Metab . 2021 Nov; 48(2):101304. PMID: 34808345
No abstract available.
2.
Fernandes V, Chaves F, Soares A, Breder I, Kimura-Medorima S, Munhoz D, et al.
Diabetes Metab . 2021 Sep; 47(6):101280. PMID: 34537385
Aim: In patients with type 2 diabetes mellitus (T2DM) a progressive thinning in the central retinal thickness (CRT) is mainly related to neuroretinal degeneration and occurs before the decline in...
3.
Wolf V, Breder I, de Carvalho L, Soares A, Cintra R, Barreto J, et al.
Nutr Diabetes . 2021 Jun; 11(1):17. PMID: 34120150
We compared the effect of dapagliflozin versus glibenclamide on the ratio of lean-to total mass in patients with type 2 diabetes mellitus, carotid subclinical atherosclerosis, HbA1c 7.0-9.0% and 40-70 years-old....
4.
Sposito A, Breder I, Soares A, Kimura-Medorima S, Munhoz D, Cintra R, et al.
Cardiovasc Diabetol . 2021 Mar; 20(1):74. PMID: 33771149
Background: The glucose-lowering independent effect of sodium glucose cotransporter-2 inhibitors (SGLT2i) on arterial wall function has not yet been clarified. This study aims to assess whether SGLT2i treatment can attenuate...
5.
Cintra R, Soares A, Breder I, Munhoz D, Barreto J, Kimura-Medorima S, et al.
Diabetol Metab Syndr . 2019 Aug; 11:62. PMID: 31384310
Background: Endothelial dysfunction (ED) is a hallmark in type 2 diabetes mellitus (T2DM) that favor both atherogenesis and ischemia and reperfusion injury (IRI). Sodium-glucose-2 co-transporter inhibitors (SGLT2i) may hypothetically improve...
6.
Sposito A, de Lima-Junior J, Moura F, Barreto J, Bonilha I, Santana M, et al.
Arterioscler Thromb Vasc Biol . 2019 Jun; 39(8):1550-1564. PMID: 31189429
Despite decades of therapeutic advances, myocardial infarction remains a leading cause of death worldwide. Recent studies have identified HDLs (high-density lipoproteins) as a potential candidate for mitigating coronary ischemia/reperfusion injury...
7.
Martins N, Mello D, Barreto J, Soares A, Breder I, Cunha J, et al.
Rev Assoc Med Bras (1992) . 2019 Feb; 65(1):3-8. PMID: 30758413
Objective: Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is...
8.
Soares A, Carvalho L, Bonilha I, Virginio V, Nadruz Junior W, Coelho-Filho O, et al.
Atherosclerosis . 2018 Dec; 281:9-16. PMID: 30583243
Background And Aims: Coronary reperfusion with HDL from healthy volunteers attenuates ischemia and reperfusion injury in animal models. In myocardial infarction (MI) patients, such an interaction is unclear. Hence, our...
9.
Soares A, Tavoni T, de Faria E, Remalay A, Maranhao R, Sposito A
Clin Chim Acta . 2017 Dec; 478:51-56. PMID: 29274325
Background: The transport of lipids from the artery wall is one of the most essential anti-atherogenic functions of high-density lipoprotein (HDL). Recent reports of changes in the HDL composition, during...
10.
Soares A, Freitas W, Japiassu A, Quaglia L, Santos S, Pereira A, et al.
J Am Soc Hypertens . 2015 Aug; 9(9):697-704. PMID: 26276450
Serum parathyroid hormone (PTH) has been found to be associated with cardiovascular mortality in the elderly, but little is known about the mechanisms underlying this association. This study investigated the...